FUBP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.542800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.449600E-01
Normal-vs-Stage2
3.938800E-01
Normal-vs-Stage3
5.679800E-02
Normal-vs-Stage4
7.893600E-01
Stage1-vs-Stage2
9.644800E-01
Stage1-vs-Stage3
2.876300E-02
Stage1-vs-Stage4
2.357600E-01
Stage2-vs-Stage3
5.421900E-02
Stage2-vs-Stage4
1.438210E-01
Stage3-vs-Stage4
2.834300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.531200E-01
Normal-vs-AfricanAmerican
7.454600E-01
Normal-vs-Asian
2.130200E-01
Caucasian-vs-AfricanAmerican
4.970400E-01
Caucasian-vs-Asian
2.567200E-01
AfricanAmerican-vs-Asian
2.465200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.962600E-01
Normal-vs-Female
3.255800E-01
Male-vs-Female
6.474800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.056200E-01
Normal-vs-Age(41-60Yrs)
7.302200E-01
Normal-vs-Age(61-80Yrs)
2.390400E-01
Normal-vs-Age(81-100Yrs)
1.224840E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.591000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.653000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.228400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.010090E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.996400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.607400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.794640E-01
Normal-vs-Daily Drinker
2.453200E-01
Normal-vs-Weekly Drinker
1.506830E-01
Normal-vs-Occasional Drinker
9.322200E-01
Normal-vs-Social Drinker
6.744000E-01
Non Drinker-vs-Daily Drinker
7.015600E-01
Non Drinker-vs-Weekly Drinker
6.447200E-01
Non Drinker-vs-Occasional Drinker
2.937900E-02
Non Drinker-vs-Social Drinker
1.597850E-01
Daily Drinker-vs-Weekly Drinker
9.524400E-01
Daily Drinker-vs-Occasional Drinker
4.179700E-02
Daily Drinker-vs-Social Drinker
1.629610E-01
Weekly Drinker-vs-Occasional Drinker
4.100000E-02
Weekly Drinker-vs-Social Drinker
1.401650E-01
Occasional Drinker-vs-Social Drinker
5.584000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.516570E-01
Normal-vs-Grade 2
1.211830E-02
Normal-vs-Grade 3
8.616400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.970490E-02
Grade 1-vs-Grade 3
3.724600E-03
Grade 1-vs-Grade 4
1.516570E-01
Grade 2-vs-Grade 3
1.565380E-01
Grade 2-vs-Grade 4
1.211830E-02
Grade 3-vs-Grade 4
8.616400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.293400E-01
Normal-vs-NonDiabetic
2.844400E-01
Diabetic-vs-NonDiabetic
6.337000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.347040E-01
Normal-vs-NoPancreatitis
3.154800E-01
Pancreatitis-vs-NoPancreatitis
6.397600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.214600E-01
Normal-vs-N1
3.591800E-01
N0-vs-N1
9.494800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.995800E-01
Normal-vs-TP53-NonMutant
4.459000E-01
TP53-Mutant-vs-TP53-NonMutant
3.337600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
